A. E. Till
Impact in
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
- Pharmacogenetics and Drug Metabolism
- Analytical Chemistry top 5%
- Analytical Methods in Pharmaceuticals
Papers in
-
- Analytical Methods in Pharmaceuticals 5
-
- Protein Hydrolysis and Bioactive Peptides 2
- Co-authors
- M Hichens (4 shared papers)HJ Gomez (3 shared papers)E H Ulm (2 shared papers)Jérôme Biollaz (1 shared paper)Elizabeth Hand (1 shared paper)John D. Irvin (3 shared papers)Helen R. Skeggs (3 shared papers)Peter H. Vlasses (2 shared papers)
- Journals
- British Journal of Clinical Pharmacology (4 papers)European Journal of Clinical Pharmacology (2 papers)Journal of Pharmaceutical Sciences (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cardiovascular Drug Reviews (1 paper)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
A. E. Till
14 papers receiving 436 citations
Peers
Comparison fields: 5 of 70
- Pharmacology 72
- Analytical Chemistry 77
- Cardiology and Cardiovascular Medicine 174
- Pharmacology 99
- Molecular Medicine 26
Countries citing papers authored by A. E. Till
This map shows the geographic impact of A. E. Till's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. E. Till with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. E. Till more than expected).
Fields of papers citing papers by A. E. Till
This network shows the impact of papers produced by A. E. Till. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. E. Till. The network helps show where A. E. Till may publish in the future.
Co-authors
The 25 scholars most cited alongside A. E. Till, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 182 | |
| 2 | 1993 | 47 | |
| 3 | 1984 | 47 | |
| 4 | 1974 | 41 | |
| 5 | 1985 | 36 | |
| 6 | 1987 | 36 | |
| 7 | 1989 | 19 | |
| 8 | 1976 | 19 | |
| 9 | 1985 | 18 | |
| 10 | 1989 | 15 | |
| 11 | BIOAVAILABILITY OF ENALAPRIL MALEATE | 1984 | 14 |
| 12 | 1979 | 12 | |
| 13 | 1980 | 3 | |
| 14 | 1975 | 1 |
About A. E. Till
A. E. Till is a scholar working on Analytical Chemistry, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine and Infectious Diseases, having authored 14 papers that have together received 490 indexed citations. Recurring topics across this work include Analytical Methods in Pharmaceuticals (5 papers), Potassium and Related Disorders (3 papers), Antibiotics Pharmacokinetics and Efficacy (3 papers), Antimicrobial Resistance in Staphylococcus (2 papers), Heart Failure Treatment and Management (2 papers), Lipoproteins and Cardiovascular Health (2 papers), Protein Hydrolysis and Bioactive Peptides (2 papers) and Pharmaceutical Practices and Patient Outcomes (1 paper). The work is most often cited by research in Pharmacology (72 citations), Analytical Chemistry (77 citations), Cardiology and Cardiovascular Medicine (174 citations), Pharmacology (99 citations) and Molecular Medicine (26 citations). A. E. Till has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include M Hichens, HJ Gomez, E H Ulm, Jérôme Biollaz, Elizabeth Hand, John D. Irvin, Helen R. Skeggs, Peter H. Vlasses, A.David Goldberg and P H Kari. Their work appears in journals such as British Journal of Clinical Pharmacology, European Journal of Clinical Pharmacology, Journal of Pharmaceutical Sciences, Journal of Pharmacology and Experimental Therapeutics and Cardiovascular Drug Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.